Safe in patients with no history of blood dyscrasia

BMJ 1995; 311 doi: 10.1136/bmj.311.7002.450a (Published 12 August 1995)
Cite this as: BMJ 1995;311:450.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. R J K Buckley,
  2. C M Kirkness,
  3. J J Kanski,
  4. A E A Ridgway,
  5. A B Tullo,
  6. P G Watson
  1. Consultant ophthalmologist Moorfields Eye Hospital, London EC1V2PD
  2. Professor of ophthalmology Tennent Institute, University of Glasgow, Western Infirmary, Glasgow G116NT
  3. Consultant ophthalmologist Prince Charles Eye Unit, King Edward VII Hospital, Windsor, Berkshire SL43DP
  4. Consultant ophthalmic surgeon Consultant ophthalmologist Manchester Royal Eye Hospital, Manchester M139WH
  5. Retired consultant ophthalmologist Addenbrooke's Hospital, Cambridge CB22QQ

    *

    EDITOR,--Chloramphenicol, in drop or ointment form, is one of the most reliable ophthalmic preparations in existence. It has a broad spectrum of activity, is well absorbed by the ocular tissues, rarely provokes resistance in micro-organisms or damages the surface of the eye, and is both cheap and widely available. The evidence that, when delivered to the eye, it can cause aplastic anaemia remains unsubstantiated. We are therefore surprised that Marie Doona and J Bernard Walsh conclude, in the absence of new …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL